Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 03:14:35 +0200Wed, 29 May 2024 15:21:00 +0200Human medicines European public assessment report (EPAR): Zessly, infliximab, Date of authorisation: 18/05/2018, Revision: 14, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/zesslyHuman medicines European public assessment report (EPAR): Zessly, infliximab, Date of authorisation: 18/05/2018, Revision: 14, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/zesslyWed, 29 May 2024 15:21:00 +0200Human medicineZessly : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4647_en_1.pdfZessly : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4647_en_1.pdfWed, 29 May 2024 13:38:00 +0200Human medicine